These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29676456)

  • 1. Differential activation of pro-survival pathways in response to CD40LG/IL4 stimulation in chronic lymphocytic leukaemia cells.
    Chen Y; Peubez C; Jayne S; Kocsis-Fodor G; Dyer MJS; Macip S
    Br J Haematol; 2019 Mar; 184(5):867-869. PubMed ID: 29676456
    [No Abstract]   [Full Text] [Related]  

  • 2. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
    Willimott S; Baou M; Naresh K; Wagner SD
    Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4.
    Willimott S; Baou M; Huf S; Deaglio S; Wagner SD
    Haematologica; 2007 Oct; 92(10):1359-66. PubMed ID: 18024373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttranscriptional Upregulation of p53 by Reactive Oxygen Species in Chronic Lymphocytic Leukemia.
    Samuel J; Jayne S; Chen Y; Majid A; Wignall A; Wormull T; Najeeb H; Luo JL; Jones GD; Macip S; Dyer MJ
    Cancer Res; 2016 Nov; 76(21):6311-6319. PubMed ID: 27634759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib inhibits B cell receptor signalling in chronic lymphocytic leukaemia but novel combination approaches are required to overcome additional pro-survival microenvironmental signals.
    McCaig AM; Cosimo E; Leach MT; Michie AM
    Br J Haematol; 2011 Apr; 153(2):199-211. PubMed ID: 21352196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
    Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
    Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.
    Ahearne MJ; Willimott S; Piñon L; Kennedy DB; Miall F; Dyer MJ; Wagner SD
    Br J Haematol; 2013 Aug; 162(3):360-70. PubMed ID: 23710828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway.
    Lafarge ST; Johnston JB; Gibson SB; Marshall AJ
    Leuk Res; 2014 Jan; 38(1):109-15. PubMed ID: 23981382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD137 is induced by the CD40 signal on chronic lymphocytic leukemia B cells and transduces the survival signal via NF-κB activation.
    Nakaima Y; Watanabe K; Koyama T; Miura O; Fukuda T
    PLoS One; 2013; 8(5):e64425. PubMed ID: 23696891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions.
    Burger JA; Gandhi V
    Blood; 2009 Sep; 114(12):2560-1; author reply 2561-2. PubMed ID: 19762501
    [No Abstract]   [Full Text] [Related]  

  • 11. Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells.
    Farahani M; Treweeke AT; Toh CH; Till KJ; Harris RJ; Cawley JC; Zuzel M; Chen H
    Leukemia; 2005 Apr; 19(4):524-30. PubMed ID: 15674425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.
    Biagi E; Rousseau R; Yvon E; Schwartz M; Dotti G; Foster A; Havlik-Cooper D; Grilley B; Gee A; Baker K; Carrum G; Rice L; Andreeff M; Popat U; Brenner M
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6916-23. PubMed ID: 16203783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection.
    Kay NE; Wasil T
    Leukemia; 2005 Apr; 19(4):531-2. PubMed ID: 15861177
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand.
    Buske C; Twiling A; Gogowski G; Schreiber K; Feuring-Buske M; Wulf GG; Hiddemann W; Wörmann B
    Leukemia; 1997 Nov; 11(11):1862-7. PubMed ID: 9369419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
    Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
    Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
    Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
    J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
    Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia.
    Willimott S; Wagner SD
    Leukemia; 2012 May; 26(5):1113-6. PubMed ID: 22024720
    [No Abstract]   [Full Text] [Related]  

  • 19. The levels of TNF alpha, IL4 and IL10 production by T-cells in B-cell chronic lymphocytic leukaemia (B-CLL).
    Mainou-Fowler T; Miller S; Proctor SJ; Dickinson AM
    Leuk Res; 2001 Feb; 25(2):157-63. PubMed ID: 11166831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells.
    Shubinsky G; Schlesinger M; Polliack A; Rabinowitz R
    Leuk Lymphoma; 1997 May; 25(5-6):521-30. PubMed ID: 9250823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.